The Broad Institute of MIT Division of Health Sciences and and MIT, Cambridge 02142, Massachusetts, USA.
Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Nat Microbiol. 2016 Jun 13;1(7):16079. doi: 10.1038/nmicrobiol.2016.79.
Human babesiosis caused by Babesia microti is an emerging tick-borne zoonosis of increasing importance due to its rising incidence and expanding geographic range(1). Infection with this organism, an intraerythrocytic parasite of the phylum Apicomplexa, causes a febrile syndrome similar to malaria(2). Relapsing disease is common among immunocompromised and asplenic individuals(3,4) and drug resistance has recently been reported(5). To investigate the origin and genetic diversity of this parasite, we sequenced the complete genomes of 42 B. microti samples from around the world, including deep coverage of clinical infections at endemic sites in the continental USA. Samples from the continental USA segregate into a Northeast lineage and a Midwest lineage, with subsequent divergence of subpopulations along geographic lines. We identify parasite variants that associate with relapsing disease, including amino acid substitutions in the atovaquone-binding regions of cytochrome b (cytb) and the azithromycin-binding region of ribosomal protein subunit L4 (rpl4). Our results shed light on the origin, diversity and evolution of B. microti, suggest possible mechanisms for clinical relapse, and create the foundation for further research on this emerging pathogen.
由微小巴贝斯虫引起的人类巴贝斯虫病是一种新兴的蜱传动物源性传染病,由于其发病率上升和地理范围扩大,越来越受到重视(1)。这种生物体是一种属于顶复门的红细胞内寄生虫,感染会引起类似于疟疾的发热综合征(2)。免疫功能低下和无脾个体中常发生复发疾病(3,4),最近也有报道称存在耐药性(5)。为了研究这种寄生虫的起源和遗传多样性,我们对来自世界各地的 42 个微小巴贝斯虫样本进行了全基因组测序,包括对美国大陆流行地区的临床感染进行了深度覆盖。来自美国大陆的样本分为东北谱系和中西部谱系,随后沿着地理线进一步分化为亚种群。我们鉴定出与复发疾病相关的寄生虫变异,包括细胞色素 b (cytb) 的阿托伐醌结合区和核糖体蛋白亚基 L4 (rpl4) 的阿奇霉素结合区的氨基酸取代。我们的研究结果阐明了微小巴贝斯虫的起源、多样性和进化,提示了临床复发的可能机制,并为进一步研究这种新兴病原体奠定了基础。